 SALT LAKE CITY , April 28, 2022 PRNewswire -- Co-Diagnostics, Inc. Nasdaq: CODX, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2022 results on Thursday, May 12, 2022, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. 